Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Surgical Oncology Fellow, Surgery, Ohio State University 2015 - 2017
  • General Surgery Resident, Surgery, Duke University 2008 - 2015
  • M.H.S., Duke University 2012
  • M.D., Duke University School of Medicine 2008
  • B.A., Duke University 2001
• 

  Duke Appointment History

  • Assistant Professor of Surgery, Surgical Oncology, Surgery 2021
  • Assistant Professor of Surgery, Surgical Oncology, Surgery 2017 - 2020
• Research
• 

  Selected Grants

  • Replimune RPL-001-16 awarded by Replimune Group, INC 2021 - 2026
  • CMP-001-011 awarded by Checkmate Pharmaceuticals 2020 - 2026
  • Checkmate CMP-001-010 awarded by Checkmate Pharmaceuticals 2020 - 2026
  • Training Program in Bioinformatics at the Intersection of Cancer Immunology and Microbiome awarded by National Institutes of Health 2020 - 2025
  • OMS-I103 / PICSES awarded by OncoSec Medical 2020 - 2025
  • PVSRIPO in melanoma awarded by National Institutes of Health 2020 - 2025
  • Investigating the Role of a Novel Dendritic Cell Subset within Sentinel Lymph Node Tissues in Immune Evasion and Melanomagenesis awarded by Department of Defense 2021 - 2024
  • Clinical Biomarker Study of the Tumor NLRP3 Inflammasome and its Role in Anti-PD-1 Immunotherapy Resistance awarded by Conquer Cancer Foundation 2021 - 2024
  • A Phase I trial of PVSRIPO for Patients with Unresectable Melanoma awarded by Istari Oncology 2018 - 2023
  • Molecular and Immunologic Characterization of In-Transit Melanoma awarded by Melanoma Research Alliance 2021 - 2022
  • A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular Melanoma awarded by Delcath Systems, Inc. 2016 - 2022
  • Tumor draining lymph node B cells as regulators of melanoma progression awarded by Department of Defense 2020 - 2021
  • Comprehensive immunologic profiling of the sentinel node to optimize care for patients with melanoma awarded by Society of Surgical Oncology 2019 - 2020
• 

  External Relationships

  • National Comprehensive Cancer Center Network
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Beasley, Georgia M., and John A. Olson. What's new in neoadjuvant therapy for breast cancer? Vol. 44, 2010. https://doi.org/10.1016/j.yasu.2010.05.013.
       Full Text  Link to Item

  • Academic Articles

    • Dikshit, Anushka, Junqi Lu, Amy E. Ford, Simone Degan, Yingai J. Jin, Huiying Sun, Amanda Nichols, et al. “Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer.” Jid Innovations 1, no. 3 (September 2021): 100043–100043. https://doi.org/10.1016/j.xjidi.2021.100043.
       Full Text
    • Sarver, Melissa, Michael C. Brown, Kristen E. Rhodin, April K. S. Salama, and Georgia M. Beasley. “Predictive factors of neoadjuvant immune checkpoint blockade in melanoma.” Hum Vaccin Immunother, July 13, 2021, 1–9. https://doi.org/10.1080/21645515.2021.1943987.
       Full Text  Link to Item
    • Broman, Kristy Kummerow, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J. Carr, Avinash Sharma, et al. “Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).” Cancer 127, no. 13 (July 1, 2021): 2251–61. https://doi.org/10.1002/cncr.33483.
       Full Text  Link to Item
    • Farrow, Norma E., Eda K. Holl, Jeanne Jung, Junheng Gao, Sin-Ho Jung, Rami N. Al-Rohil, Maria A. Selim, et al. “Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.” Ann Surg Oncol 28, no. 7 (July 2021): 3501–10. https://doi.org/10.1245/s10434-020-09277-w.
       Full Text  Link to Item
    • Straker, Richard J., Yun Song, James Sun, Adrienne B. Shannon, Leah S. Cohen, Elnara Muradova, Hala Daou, et al. “Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.” Ann Surg Oncol 28, no. 7 (July 2021): 3512–21. https://doi.org/10.1245/s10434-020-09384-8.
       Full Text  Link to Item
    • Farrow, Nellie E., Kristen E. Rhodin, and Georgia M. Beasley. “Nodal Recurrence as Primary Driver of Early Relapse in Patients with SLN-Positive Melanoma: What Does It Mean for Providers and Patients?” Ann Surg Oncol 28, no. 7 (July 2021): 3452–54. https://doi.org/10.1245/s10434-021-09806-1.
       Full Text  Link to Item
    • Farrow, Norma E., and Georgia M. Beasley. “ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.” Annals of Surgical Oncology 28, no. 7 (July 2021): 3511. https://doi.org/10.1245/s10434-021-09595-7.
       Full Text
    • DeVito, Nicholas C., Michael Sturdivant, Balamayooran Thievanthiran, Christine Xiao, Michael P. Plebanek, April K. S. Salama, Georgia M. Beasley, et al. “Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.” Cell Rep 35, no. 5 (May 4, 2021): 109071. https://doi.org/10.1016/j.celrep.2021.109071.
       Full Text  Link to Item
    • Lee, Ann Y., Erica B. Friedman, James Sun, Aishwarya Potdar, Hala Daou, Norma E. Farrow, Clara R. Farley, et al. “Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.” Ann Surg Oncol, April 23, 2021. https://doi.org/10.1245/s10434-021-10047-5.
       Full Text  Link to Item
    • Straker, Richard J., Michael J. Carr, Andrew J. Sinnamon, Adrienne B. Shannon, James Sun, Karenia Landa, Kirsten M. Baecher, et al. “Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma.” Ann Surg Oncol, April 22, 2021. https://doi.org/10.1245/s10434-021-10031-z.
       Full Text  Link to Item
    • Beasley, Georgia M., Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin-Ho Jung, et al. “Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.” Journal for Immunotherapy of Cancer 9, no. 4 (April 2021). https://doi.org/10.1136/jitc-2020-002203.
       Full Text
    • Broman, Kristy K., Tasha M. Hughes, Lesly A. Dossett, James Sun, Michael J. Carr, Dennis A. Kirichenko, Avinash Sharma, et al. “Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.” J Am Coll Surg 232, no. 4 (April 2021): 424–31. https://doi.org/10.1016/j.jamcollsurg.2020.11.014.
       Full Text  Link to Item
    • Brown, Michael C., Mubeen M. Mosaheb, Malte Mohme, Zachary P. McKay, Eda K. Holl, Jonathan P. Kastan, Yuanfan Yang, et al. “Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling.” Nature Communications 12, no. 1 (March 25, 2021): 1858. https://doi.org/10.1038/s41467-021-22088-1.
       Full Text
    • Salama, April K. S., Manisha Palta, Christel N. Rushing, M Angelica Selim, Kristen N. Linney, Brian G. Czito, David S. Yoo, et al. “Ipilimumab and Radiation in Patients with High-risk Resected or Regionally Advanced Melanoma.” Clin Cancer Res 27, no. 5 (March 1, 2021): 1287–95. https://doi.org/10.1158/1078-0432.CCR-20-2452.
       Full Text  Link to Item
    • Beasley, Georgia M., Aaron D. Therien, Eda K. Holl, Rami Al-Rohil, Maria Angelica Selim, Nellie E. Farrow, Liuliu Pan, et al. “Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection.” Cancer Immunol Immunother 70, no. 2 (February 2021): 475–83. https://doi.org/10.1007/s00262-020-02698-2.
       Full Text  Link to Item
    • Beasley, Georgia M. “Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes.” Ann Surg Oncol 27, no. 13 (December 2020): 4870–71. https://doi.org/10.1245/s10434-020-09114-0.
       Full Text  Link to Item
    • Carr, Michael J., James Sun, Hidde M. Kroon, John T. Miura, Georgia M. Beasley, Norma E. Farrow, Paul J. Mosca, et al. “Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia.” Ann Surg Oncol 27, no. 13 (December 2020): 5107–18. https://doi.org/10.1245/s10434-020-09051-y.
       Full Text  Link to Item
    • Farrow, Norma E., and Georgia M. Beasley. “ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy.” Ann Surg Oncol 27, no. 13 (December 2020): 5126–27. https://doi.org/10.1245/s10434-020-08561-z.
       Full Text  Link to Item
    • Farrow, Norma E., Vignesh Raman, Taylor P. Williams, Kayla Y. Nguyen, Douglas S. Tyler, and Georgia M. Beasley. “Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.” Annals of Surgical Oncology 27, no. 13 (December 2020): 5121–25. https://doi.org/10.1245/s10434-020-08478-7.
       Full Text
    • Ravichandran, Surya, Neel Nath, David C. Jones, Gabriel Li, Visakha Suresh, Adam K. Brys, Brent A. Hanks, et al. “The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma.” Surg Oncol 35 (December 2020): 533–39. https://doi.org/10.1016/j.suronc.2020.10.018.
       Full Text  Link to Item
    • Hu, Janice, Sabran J. Masoud, Surya Ravichandran, Georgia M. Beasley, and Paul J. Mosca. “Retreatment with talimogene laherparepvec for advanced melanoma.” Immunotherapy 12, no. 16 (November 2020): 1167–72. https://doi.org/10.2217/imt-2020-0029.
       Full Text  Link to Item
    • Beasley, Georgia M. “Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma.” Ann Surg Oncol 27, no. 9 (September 2020): 3121–22. https://doi.org/10.1245/s10434-020-08460-3.
       Full Text  Link to Item
    • Hu, Janice B., Surya Ravichandran, Christel Rushing, Georgia M. Beasley, Brent A. Hanks, Sin-Ho Jung, April K. S. Salama, Lisa Ho, and Paul J. Mosca. “Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma.” Anticancer Res 40, no. 9 (September 2020): 5245–54. https://doi.org/10.21873/anticanres.14528.
       Full Text  Link to Item
    • Farrow, Norma E., Margaret Leddy, Karenia Landa, and Georgia M. Beasley. “Injectable Therapies for Regional Melanoma.” Surg Oncol Clin N Am 29, no. 3 (July 2020): 433–44. https://doi.org/10.1016/j.soc.2020.02.008.
       Full Text  Link to Item
    • Dalal, Nicole H., Fumiko Chino, Hannah Williamson, Georgia M. Beasley, April K. S. Salama, and Manisha Palta. “Mind the gap: Gendered publication trends in oncology.” Cancer 126, no. 12 (June 15, 2020): 2859–65. https://doi.org/10.1002/cncr.32818.
       Full Text  Link to Item
    • Teras, Jüri, Hidde M. Kroon, John T. Miura, Tim Kenyon-Smith, Georgia M. Beasley, Dean Mullen, Norma E. Farrow, et al. “International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.” Ann Surg Oncol 27, no. 5 (May 2020): 1420–29. https://doi.org/10.1245/s10434-020-08312-0.
       Full Text  Link to Item
    • Beasley, Georgia M., Jonathan S. Zager, and John F. Thompson. “The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma.” Ann Surg Oncol 27, no. 1 (January 2020): 35–42. https://doi.org/10.1245/s10434-019-07760-7.
       Full Text  Link to Item
    • Kwak, Minyoung, Yun Song, Phyllis A. Gimotty, Norma E. Farrow, Andrew D. Tieniber, Jonathan G. Davick, Gabriella N. Tortorello, Georgia M. Beasley, Craig L. Slingluff, and Giorgos C. Karakousis. “Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.” Ann Surg Oncol 26, no. Suppl 3 (December 2019): 893. https://doi.org/10.1245/s10434-019-08046-8.
       Full Text  Link to Item
    • Kwak, Minyoung, Yun Song, Phyllis A. Gimotty, Norma E. Farrow, Andrew D. Tieniber, Jonathan G. Davick, Gabriella N. Tortorello, Georgia M. Beasley, Craig L. Slingluff, and Giorgos C. Karakousis. “Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.” Ann Surg Oncol 26, no. 12 (November 2019): 3962–71. https://doi.org/10.1245/s10434-019-07694-0.
       Full Text  Link to Item
    • Masoud, Sabran J., Jennifer A. Perone, Norma E. Farrow, Paul J. Mosca, Douglas S. Tyler, and Georgia M. Beasley. “Correction to: Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.” Curr Treat Options Oncol 20, no. 10 (August 29, 2019): 76. https://doi.org/10.1007/s11864-019-0674-x.
       Full Text  Link to Item
    • Puza, C. J., S. A. Myers, A. R. Cardones, G. M. Beasley, and P. J. Mosca. “The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients.” Clin Exp Dermatol 44, no. 3 (April 2019): 265–69. https://doi.org/10.1111/ced.13699.
       Full Text  Link to Item
    • Puza, Charles J., Elizabeth Schell Bressler, Alicia M. Terando, John Harrison Howard, Michael C. Brown, Brent Hanks, April K. S. Salama, and Georgia M. Beasley. “The Emerging Role of Surgery for Patients With Advanced Melanoma Treated With Immunotherapy.” J Surg Res 236 (April 2019): 209–15. https://doi.org/10.1016/j.jss.2018.11.045.
       Full Text  Link to Item
    • Kwak, Minyoung, Norma E. Farrow, April K. S. Salama, Paul J. Mosca, Brent A. Hanks, Craig L. Slingluff, and Georgia M. Beasley. “Updates in adjuvant systemic therapy for melanoma.” J Surg Oncol 119, no. 2 (January 2019): 222–31. https://doi.org/10.1002/jso.25298.
       Full Text  Link to Item
    • Holl, Eda K., Victoria N. Frazier, Karenia Landa, Georgia M. Beasley, E Shelley Hwang, and Smita K. Nair. “Examining Peripheral and Tumor Cellular Immunome in Patients With Cancer.” Front Immunol 10 (2019): 1767. https://doi.org/10.3389/fimmu.2019.01767.
       Full Text  Link to Item
    • Masoud, Sabran J., Jennifer A. Perone, Norma E. Farrow, Paul J. Mosca, Douglas S. Tyler, and Georgia M. Beasley. “Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.” Curr Treat Options Oncol 19, no. 11 (September 19, 2018): 55. https://doi.org/10.1007/s11864-018-0575-4.
       Full Text  Link to Item
    • Puza, Charles J., Srirama Josyula, Alicia M. Terando, John H. Howard, Doreen M. Agnese, Paul J. Mosca, Walter T. Lee, and Georgia M. Beasley. “Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?” J Surg Oncol 117, no. 7 (June 2018): 1584–88. https://doi.org/10.1002/jso.25025.
       Full Text  Link to Item
    • Perone, Jennifer A., Nellie Farrow, Douglas S. Tyler, and Georgia M. Beasley. “Contemporary Approaches to In-Transit Melanoma.” J Oncol Pract 14, no. 5 (May 2018): 292–300. https://doi.org/10.1200/JOP.18.00063.
       Full Text  Link to Item
    • Rossfeld, Kara, Erinn M. Hade, Alexandra Gangi, Matthew Perez, Emily N. Kinsey, Joanna Grabska, Ashley Ederle, et al. “Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics.” Int J Surg Oncol (N Y) 2, no. 9 (October 2017): e43. https://doi.org/10.1097/IJ9.0000000000000043.
       Full Text  Link to Item
    • Beasley, Georgia M., Yinin Hu, Linda Youngwirth, Randall P. Scheri, April K. Salama, Kara Rossfeld, Syed Gardezi, et al. “Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.” Ann Surg Oncol 24, no. 9 (September 2017): 2728–33. https://doi.org/10.1245/s10434-017-5883-6.
       Full Text  Link to Item
    • Kurtz, James, Georgia M. Beasley, Doreen Agnese, Kari Kendra, Thomas E. Olencki, Alicia Terando, and J Harrison Howard. “Surveillance strategies in the follow-up of melanoma patients: too much or not enough?” J Surg Res 214 (June 15, 2017): 32–37. https://doi.org/10.1016/j.jss.2017.02.070.
       Full Text  Link to Item
    • Beasley, G. M., J. Kurtz, J. Vandeusen, J. H. Howard, A. Terando, D. Agnese, D. Liebner, J. Jeter, and T. Olencki. “Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma.” Clinical Skin Cancer, April 5, 2017. https://doi.org/10.1016/j.clsc.2017.04.001.
       Full Text
    • Turner, Megan C., Kara Rossfeld, April K. S. Salama, Douglas Tyler, and Georgia Beasley. “Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?” Expert Opin Pharmacother 18, no. 5 (April 2017): 487–95. https://doi.org/10.1080/14656566.2017.1299710.
       Full Text  Link to Item
    • Brys, Adam K., Lubna Bhatti, Mustafa R. Bashir, Tracy A. Jaffe, Georgia M. Beasley, Neel S. Nath, April K. S. Salama, Douglas S. Tyler, and Paul J. Mosca. “Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.” Ann Surg Oncol 23, no. 4 (April 2016): 1090–95. https://doi.org/10.1245/s10434-015-4972-7.
       Full Text  Link to Item
    • Beasley, Georgia M., Theodore N. Pappas, and Allan D. Kirk. “Procedure Delegation by Attending Surgeons Performing Concurrent Operations in Academic Medical Centers: Balancing Safety and Efficiency.” Ann Surg 261, no. 6 (June 2015): 1044–45. https://doi.org/10.1097/SLA.0000000000001208.
       Full Text  Link to Item
    • Beasley, Georgia, and Douglas Tyler. “In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy.” Ann Surg Oncol 22, no. 2 (February 2015): 358–60. https://doi.org/10.1245/s10434-014-4110-y.
       Full Text  Link to Item
    • Muilenburg, Diego J., Georgia M. Beasley, Zachary J. Thompson, Ji-Hyun Lee, Douglas S. Tyler, and Jonathan S. Zager. “Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.” Ann Surg Oncol 22, no. 2 (February 2015): 482–88. https://doi.org/10.1245/s10434-014-4072-0.
       Full Text  Link to Item
    • Jiang, Betty S., Georgia M. Beasley, Paul J. Speicher, Paul J. Mosca, Michael A. Morse, Brent Hanks, April Salama, and Douglas S. Tyler. “Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma.” Ann Surg Oncol 21, no. 8 (August 2014): 2525–31. https://doi.org/10.1245/s10434-014-3671-0.
       Full Text  Link to Item
    • Beasley, Georgia M., Truls Ostbye, Lawrence H. Muhlbaier, Carolyn Foley, John Scarborough, Ryan S. Turley, and Mark L. Shapiro. “Age and gender differences in substance screening may underestimate injury severity: a study of 9793 patients at level 1 trauma center from 2006 to 2010.” J Surg Res 188, no. 1 (May 1, 2014): 190–97. https://doi.org/10.1016/j.jss.2013.11.1103.
       Full Text  Link to Item
    • Speicher, Paul J., Georgia M. Beasley, Betty Jiang, Michael E. Lidsky, Gregory M. Palmer, Peter M. Scarbrough, Paul J. Mosca, Mark W. Dewhirst, and Douglas S. Tyler. “Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.” Ann Surg Oncol 21, no. 5 (May 2014): 1435–40. https://doi.org/10.1245/s10434-013-3222-0.
       Full Text  Link to Item
    • Beasley, Georgia M., Paul Speicher, Ketan Sharma, Hilliard Seigler, April Salama, Paul Mosca, and Douglas S. Tyler. “Efficacy of repeat sentinel lymph node biopsy in patients who develop recurrent melanoma.” J Am Coll Surg 218, no. 4 (April 2014): 686–92. https://doi.org/10.1016/j.jamcollsurg.2013.12.025.
       Full Text  Link to Item
    • Slingluff, Craig, Keith Delman, Kelly McMasters, and Georgia Beasley. “Efficacy of Repeat Sentinel Lymph Node Biopsy in Patients Who Develop Recurrent Melanoma Discussion.” Journal of the American College of Surgeons 218, no. 4 (April 1, 2014): 692–94.
       Link to Item
    • “Discussion.” J Am Coll Surg 218, no. 4 (April 2014): 692–94. https://doi.org/10.1016/j.jamcollsurg.2014.01.020.
       Full Text  Link to Item
    • Tokuhisa, Yoshihiro, Michael E. Lidsky, Hiroaki Toshimitsu, Ryan S. Turley, Georgia M. Beasley, Tomio Ueno, Ketan Sharma, Christina K. Augustine, and Douglas S. Tyler. “SRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma.” Ann Surg Oncol 21, no. 3 (March 2014): 1024–30. https://doi.org/10.1245/s10434-013-3387-6.
       Full Text  Link to Item
    • Wong, Joyce, Y Ann Chen, Kate J. Fisher, Georgia M. Beasley, Douglas S. Tyler, and Jonathan S. Zager. “Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.” Ann Surg Oncol 21, no. 2 (February 2014): 650–55. https://doi.org/10.1245/s10434-013-3336-4.
       Full Text  Link to Item
    • Hanks, Brent A., Alisha Holtzhausen, Katherine S. Evans, Rebekah Jamieson, Petra Gimpel, Olivia M. Campbell, Melissa Hector-Greene, et al. “Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.” J Clin Invest 123, no. 9 (September 2013): 3925–40. https://doi.org/10.1172/JCI65745.
       Full Text  Open Access Copy  Link to Item
    • Augustine, C. K., J. A. Freedman, G. M. Beasley, and D. S. Tyler. “Melanoma” 2 (August 29, 2013): 765–75. https://doi.org/10.1016/B978-0-12-382227-7.00066-5.
       Full Text
    • Lidsky, Michael E., Ryan S. Turley, Georgia M. Beasley, Ketan Sharma, and Douglas S. Tyler. “Predicting disease progression after regional therapy for in-transit melanoma.” Jama Surg 148, no. 6 (June 2013): 493–98. https://doi.org/10.1001/jamasurg.2013.695.
       Full Text  Link to Item
    • Shetty, Gina, Georgia M. Beasley, Sara Sparks, Michael Barfield, Melanie Masoud, Paul J. Mosca, Scott K. Pruitt, et al. “Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion.” Ann Surg Oncol 20, no. 4 (April 2013): 1128–35. https://doi.org/10.1245/s10434-012-2785-5.
       Full Text  Link to Item
    • Li, George Z., Jason L. Sloane, Michael E. Lidsky, Georgia M. Beasley, Srinevas K. Reddy, John E. Scarborough, Douglas S. Tyler, Ryan S. Turley, and Bryan M. Clary. “Simultaneous diaphragm and liver resection: a propensity-matched analysis of postoperative morbidity.” J Am Coll Surg 216, no. 3 (March 2013): 402–11. https://doi.org/10.1016/j.jamcollsurg.2012.11.001.
       Full Text  Link to Item
    • Beasley, Georgia M., Ketan Sharma, Joyce Wong, Mike Miller, Ryan S. Turley, Michael Lidsky, Melanie Masoud, et al. “A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.” Cancer 118, no. 24 (December 15, 2012): 6136–43. https://doi.org/10.1002/cncr.27676.
       Full Text  Link to Item
    • Beasley, G. M., A. P. Coleman, A. Raymond, G. Sanders, M. A. Selim, B. L. Peterson, M. S. Brady, M. A. Davies, C. Augustine, and D. S. Tyler. “A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity.” Ann Surg Oncol 19, no. 12 (November 2012): 3896–3905. https://doi.org/10.1245/s10434-012-2373-8.
       Full Text  Link to Item
    • Beasley, Georgia M., Colin Parsons, Gloria Broadwater, M Angelica Selim, Suroosh Marzban, Amy P. Abernethy, April K. S. Salama, et al. “A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.” Ann Surg 256, no. 2 (August 2012): 350–56. https://doi.org/10.1097/SLA.0b013e318256d1f5.
       Full Text  Link to Item
    • Sharma, Ketan, Georgia Beasley, Ryan Turley, Amanda K. Raymond, Gloria Broadwater, Bercedis Peterson, Paul Mosca, and Douglas Tyler. “Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.” Ann Surg Oncol 19, no. 8 (August 2012): 2563–71. https://doi.org/10.1245/s10434-012-2315-5.
       Full Text  Link to Item
    • Turley, Ryan S., Andrew N. Fontanella, James C. Padussis, Hiroaki Toshimitsu, Yoshihiro Tokuhisa, Eugenia H. Cho, Gabi Hanna, et al. “Bevacizumab-induced alterations in vascular permeability and drug delivery: a novel approach to augment regional chemotherapy for in-transit melanoma.” Clin Cancer Res 18, no. 12 (June 15, 2012): 3328–39. https://doi.org/10.1158/1078-0432.CCR-11-3000.
       Full Text  Link to Item
    • Chai, Christy Y., Jeremiah L. Deneve, Georgia M. Beasley, Suroosh S. Marzban, Y Ann Chen, Bhupendra Rawal, Stephen R. Grobmyer, Steven N. Hochwald, Douglas S. Tyler, and Jonathan S. Zager. “A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.” Ann Surg Oncol 19, no. 5 (May 2012): 1637–43. https://doi.org/10.1245/s10434-011-2151-z.
       Full Text  Link to Item
    • Raymond, A. K., G. M. Beasley, and G. Broadwater. “Erratum: Current trends in regional therapy for melanoma: Lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution (Journal of the American College of Surgeons (2011) 213 (306-318)).” Journal of the American College of Surgeons 214, no. 2 (February 1, 2012): 245. https://doi.org/10.1016/j.jamcollsurg.2011.10.013.
       Full Text
    • Beasley, Georgia M., and Douglas S. Tyler. “Treatment of in-transit melanoma: an opportunity to discover critical knowledge.” Oncology (Williston Park) 25, no. 14 (December 2011): 1351–55.
       Link to Item
    • Han, Dale, Georgia M. Beasley, Douglas S. Tyler, and Jonathan S. Zager. “Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.” Expert Opin Drug Metab Toxicol 7, no. 11 (November 2011): 1383–94. https://doi.org/10.1517/17425255.2011.609555.
       Full Text  Link to Item
    • Raymond, Amanda K., Georgia M. Beasley, Gloria Broadwater, Christina K. Augustine, James C. Padussis, Ryan Turley, Bercedis Peterson, Hilliard Seigler, Scott K. Pruitt, and Douglas S. Tyler. “Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.” J Am Coll Surg 213, no. 2 (August 2011): 306–16. https://doi.org/10.1016/j.jamcollsurg.2011.03.013.
       Full Text  Link to Item
    • Beasley, Georgia M., and Douglas S. Tyler. “Standardizing regional therapy: developing a consensus on optimal utilization of regional chemotherapy treatments in melanoma.” Ann Surg Oncol 18, no. 7 (July 2011): 1814–18. https://doi.org/10.1245/s10434-011-1656-9.
       Full Text  Link to Item
    • Turaga, Kiran K., Georgia M. Beasley, John M. Kane, Keith A. Delman, Stephen R. Grobmyer, Ricardo J. Gonzalez, G Douglas Letson, David Cheong, Douglas S. Tyler, and Jonathan S. Zager. “Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.” Arch Surg 146, no. 7 (July 2011): 870–75. https://doi.org/10.1001/archsurg.2011.139.
       Full Text  Link to Item
    • Beasley, Georgia M., Jonathan C. Riboh, Christina K. Augustine, Jonathan S. Zager, Steven N. Hochwald, Stephen R. Grobmyer, Bercedis Peterson, Richard Royal, Merrick I. Ross, and Douglas S. Tyler. “Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.” J Clin Oncol 29, no. 9 (March 20, 2011): 1210–15. https://doi.org/10.1200/JCO.2010.32.1224.
       Full Text  Link to Item
    • Augustine, Christina K., Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M Angelica Selim, et al. “Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.” Mol Cancer Ther 9, no. 7 (July 2010): 2090–2101. https://doi.org/10.1158/1535-7163.MCT-10-0073.
       Full Text  Link to Item
    • Coleman, Andrew, Christina K. Augustine, Georgia Beasley, Gretchen Sanders, and Douglas Tyler. “Optimizing regional infusion treatment strategies for melanoma of the extremities.” Expert Rev Anticancer Ther 9, no. 11 (November 2009): 1599–1609. https://doi.org/10.1586/era.09.126.
       Full Text  Link to Item
    • Beasley, Georgia M., Nicole McMahon, Gretchen Sanders, Christina K. Augustine, Maria A. Selim, Bercedis Peterson, Robin Norris, William P. Peters, Merrick I. Ross, and Douglas S. Tyler. “A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.” Cancer 115, no. 20 (October 15, 2009): 4766–74. https://doi.org/10.1002/cncr.24509.
       Full Text  Link to Item
    • Santillan, Alfredo A., Keith A. Delman, Georgia M. Beasley, Paul J. Mosca, Steven N. Hochwald, Stephen R. Grobmyer, Robert H. Andtbacka, et al. “Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.” Ann Surg Oncol 16, no. 9 (September 2009): 2570–78. https://doi.org/10.1245/s10434-009-0563-9.
       Full Text  Link to Item
    • Ceppa, Eugene P., Bantayehu Sileshi, Georgia M. Beasley, and Jeffrey H. Lawson. “Surgical excision of infected arteriovenous grafts: technique and review.” J Vasc Access 10, no. 3 (July 2009): 148–52. https://doi.org/10.1177/112972980901000302.
       Full Text  Link to Item
    • Beasley, Georgia M., Abigail Caudle, Rebecca P. Petersen, Nicole S. McMahon, James Padussis, Paul J. Mosca, Jonathan S. Zager, et al. “A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.” J Am Coll Surg 208, no. 5 (May 2009): 706–15. https://doi.org/10.1016/j.jamcollsurg.2008.12.019.
       Full Text  Link to Item
    • Beasley, Georgia M., and Douglas S. Tyler. “Optimizing regional therapy for melanoma.” Ann Surg Oncol 16, no. 5 (May 2009): 1095–97. https://doi.org/10.1245/s10434-009-0329-4.
       Full Text  Link to Item
    • Bland, Kirby I., Kelly M. McMasters, Roger R. Perry, Edward M. Copeland, and Georgia M. Beasley. “A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US Discussion.” Journal of the American College of Surgeons 208, no. 5 (May 1, 2009): 715–17.
       Link to Item
    • McMahon, N., T. Y. Cheng, G. M. Beasley, I. Spasojevic, W. Petros, C. K. Augustine, P. Zipfel, J. C. Padussis, G. Sanders, and Douglas S. Tyler. “Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?” Ann Surg Oncol 16, no. 4 (April 2009): 953–61. https://doi.org/10.1245/s10434-008-0288-1.
       Full Text  Link to Item
    • Beasley, Georgia M., Lauren Kahn, and Douglas S. Tyler. “Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.” Surg Oncol Clin N Am 17, no. 4 (October 2008): 731–viii. https://doi.org/10.1016/j.soc.2008.04.002.
       Full Text  Link to Item
    • Beasley, Georgia M., Rebecca P. Petersen, Jin Yoo, Nicole McMahon, Thomas Aloia, William Petros, Gretchen Sanders, et al. “Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.” Ann Surg Oncol 15, no. 8 (August 2008): 2195–2205. https://doi.org/10.1245/s10434-008-9988-9.
       Full Text  Link to Item
    • Beasley, G. M., M. I. Ross, and D. S. Tyler. “Future directions in regional treatment strategies for melanoma and sarcoma.” Int J Hyperthermia 24, no. 3 (May 2008): 301–9. https://doi.org/10.1080/02656730701827573.
       Full Text  Link to Item
    • “Letter to the editor.” International Journal of Hyperthermia 24, no. 7 (January 2008): 604–604. https://doi.org/10.1080/02656730802235544.
       Full Text

  • Book Sections

    • Beasley, G., and D. G. Blazer. “Hepatic abscess.” In Contemporary Surgical Management of Liver, Biliary Tract, and Pancreatic Disease, 35–46, 2013. https://doi.org/10.1142/9789814293068_0003.
       Full Text

  • Conference Papers

    • Shannon, A. B., M. J. Carr, R. J. Straker, J. Sun, K. Landa, K. Baecher, K. Lynch, et al. “A Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.” In Annals of Surgical Oncology, 28:S29–S29, 2021.
       Link to Item
    • Straker, R. J., M. J. Carr, A. J. Sinnamon, A. B. Shannon, J. Sun, K. Landa, K. Baecher, et al. “Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma.” In Annals of Surgical Oncology, 28:S28–S28, 2021.
       Link to Item
    • Lee, Ann Y., Erica B. Friedman, James Sun, Aishwarya Potdar, Hala Daou, Norma E. Farrow, Clara R. Farley, et al. “The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.” In Ann Surg Oncol, 27:5259–66, 2020. https://doi.org/10.1245/s10434-020-08708-y.
       Full Text  Link to Item
    • Beasley, Georgia, Nellie Farrow, Karenia Landa, Maria Angelica Seilm, Sin-Ho Jung, Darell Bigner, Andrea True Kelly, Smita Nair, Matthias Gromeier, and April Salama. “302 A phase I trial of intratumoral PVSRIPO in patients with unresectable treatment refractory melanoma.” In Journal for Immunotherapy of Cancer, 8:A329–A329. BMJ, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0302.
       Full Text
    • DeVito, Nicholas, Michael Sturdivant, Luke Wachsmuth, John Strickler, Georgia Beasley, Rami Al-Rohil, April Salama, and Brent Hanks. “425 Investigation of Wnt ligand signaling regulators as a predictor of Anti-PD-1 response in metastatic melanoma.” In Journal for Immunotherapy of Cancer, 8:A450–A450. BMJ, 2020. https://doi.org/10.1136/jitc-2020-sitc2020.0425.
       Full Text
    • Kenyon-Smith, Timothy J., Hidde M. Kroon, John T. Miura, Jüri Teras, Georgia M. Beasley, Dean Mullen, Norma E. Farrow, et al. “Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.” In Eur J Surg Oncol, 46:2140–46, 2020. https://doi.org/10.1016/j.ejso.2020.06.040.
       Full Text  Link to Item
    • Beasley, Georgia M., Eda K. Holl, Norma E. Farrow, Margaret G. Leddy, April K. Salama, Brent A. Hanks, and Smita K. Nair. “The immune profile of sentinel lymph nodes in melanoma.” In Cancer Research, 80:51–52, 2020.
       Link to Item
    • Lee, Jinho, Marilyne Labrie, Gen Yong, Todd Camp, Hongli Ma, Megan Grout, Wei Xu, et al. “Multiomics profiling of longitudinal melanoma specimens unravels molecular mechanisms of resistance to sequential targeted and cancer immunotherapies.” In Journal of Clinical Oncology, Vol. 38, 2020.
       Link to Item
    • Broman, K., T. M. Hughes, L. A. Dossett, J. Sun, D. Kirichenko, M. J. Carr, T. J. Hieken, et al. “Active Surveillance of Melanoma Patients with Sentinel Node Metastasis: An International Multi-Institution Evaluation of Post-MSLT-2 Adoption and Early Outcomes.” In Annals of Surgical Oncology, 27:S30–31. SPRINGER, 2020.
       Link to Item
    • Eckhoff, A. M., N. E. Farrow, C. Silvestri, E. Stroobant, M. Leddy, D. S. Tyler, A. Berger, and G. M. Beasley. “40-Minutes is Enough: Lymphoscintigraphy with Novel Agent Reduces Time Needed for Mapping.” In Annals of Surgical Oncology, 27:S198–S198. SPRINGER, 2020.
       Link to Item
    • Farrow, N. E., E. K. Holl, J. Jung, J. Gao, S. Jung, R. Al-Rohil, P. Mosca, et al. “An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma.” In Annals of Surgical Oncology, 27:S32–S32. SPRINGER, 2020.
       Link to Item
    • Farrow, N. E., G. M. Beasley, A. S. MacLeod, M. A. Sarah, A. Cognetta, M. Gromeier, M. A. Selim, D. D. Bigner, R. McLendon, and M. J. Whitley. “Expression of CD155, PD-1 and PD-L1 in Non-Melanoma Skin Cancer: Implications for Treatment of Advanced Disease.” In Annals of Surgical Oncology, 27:S204–S204. SPRINGER, 2020.
       Link to Item
    • Sun, J., H. M. Kroon, J. T. Miura, G. M. Beasley, N. E. Farrow, P. Mosca, M. C. Lowe, et al. “Oncologic Outcomes After Isolated Limb Infusion (ILI) for Advanced Melanoma: An International Comparison between the US and Australia.” In Annals of Surgical Oncology, 27:S35–S35. SPRINGER, 2020.
       Link to Item
    • Masoud, Sabran J., Janice B. Hu, Georgia M. Beasley, John H. Stewart, and Paul J. Mosca. “Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size.” In Ann Surg Oncol, 26:4633–41, 2019. https://doi.org/10.1245/s10434-019-07691-3.
       Full Text  Link to Item
    • Dalal, N. H., F. Chino, H. Williamson, G. Beasley, A. K. S. Salama, and M. Palta. “Mind the Gap: Gendered Publication Trends in Academic Oncology.” In International Journal of Radiation Oncology*Biology*Physics, 105:E146–E146. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2198.
       Full Text
    • Miura, John T., Hidde M. Kroon, Georgia M. Beasley, Dean Mullen, Norma E. Farrow, Paul J. Mosca, Michael C. Lowe, et al. “Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.” In Ann Surg Oncol, 26:2486–94, 2019. https://doi.org/10.1245/s10434-019-07288-w.
       Full Text  Link to Item
    • Farrow, N. E., M. C. Turner, A. K. Salama, H. F. Seigler, D. S. Tyler, and G. Beasley. “Overall Survival Improved for Contemporary Patients with Melanoma.” In Annals of Surgical Oncology, 26:S162–S162. SPRINGER, 2019.
       Link to Item
    • Kwak, M., Y. Song, P. A. Gimotty, N. E. Farrow, A. D. Tieniber, J. G. Davick, G. N. Tortorello, G. Beasley, C. L. Slingluff, and G. Karakousis. “Extent of Lymphadenectomy in Patients with Melanoma and Clinical Node Disease.” In Annals of Surgical Oncology, 26:S43–S43. SPRINGER, 2019.
       Link to Item
    • Lee, A. Y., E. Friedman, J. Sun, A. Potdar, H. Daou, N. E. Farrow, C. Farley, et al. “Substage-Specific Survival in Acral Lentiginous Melanoma.” In Annals of Surgical Oncology, 26:S158–S158. SPRINGER, 2019.
       Link to Item
    • Puza, C. J., S. A. Myers, A. R. Cardones, G. M. Beasley, and P. J. Mosca. “291 The effect of rejection episodes on squamous cell carcinoma (SCC) in transplant patients.” In Journal of Investigative Dermatology, 138:S50–S50. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.03.297.
       Full Text
    • Puza, C. J., S. Josyula, D. M. Agnese, J. Howard, A. M. Terando, P. J. Mosca, W. T. Lee, and G. Beasley. “Is the Number of Sentinel Lymph Nodes Important for Head and Neck Melanoma Staging?” In Annals of Surgical Oncology, 25:S172–S172. SPRINGER, 2018.
       Link to Item
    • Amireskandari, Annahita, Georgia Beasley, Anne Kunkler, Srinivas Kondapalli, Thomas Olencki, Mark Bloomston, Carl Schmidt, et al. “Hepatic arterial melphalan perfusion of liver predominant uveal melanoma metastasis.” In Investigative Ophthalmology & Visual Science, Vol. 58. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2017.
       Link to Item
    • Beasley, G., J. Kurtz, J. H. Howard, A. Terando, D. Agnese, L. David, and T. Olencki. “Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous Cell Carcinoma.” In Annals of Surgical Oncology, 24:S37–S37. SPRINGER, 2017.
       Link to Item
    • Beasley, G., Y. Hu, L. Youngwirth, R. P. Scheri, A. Salama, K. Rossfeld, S. K. Gardezi, et al. “Multicenter Study of the Prognostic Value of Sentinel Lymph Node Biopsy in the Management of Recurrent Melanoma.” In Annals of Surgical Oncology, 24:S16–S16. SPRINGER, 2017.
       Link to Item
    • Muilenburg, D. J., G. M. Beasley, Z. J. Thompson, J. Lee, D. S. Tyler, and J. S. Zager. “Disease Burden Predicts Response to Melphalan-based Isolated Limb Infusion in Melanoma.” In Annals of Surgical Oncology, 21:S23–S23. SPRINGER, 2014.
       Link to Item
    • Beasley, G., P. Speicher, K. Sharma, B. Jiang, M. Lidsky, K. Bronson, P. Mosca, and D. S. Tyler. “Sentinel Lymph Node Biopsy to Guide Management in Patients with Locally Recurrent Melanoma.” In Annals of Surgical Oncology, 20:S96–S96. SPRINGER, 2013.
       Link to Item
    • Beasley, G., J. Wong, K. Sharma, R. Turley, L. Michael, J. S. Zager, and D. S. Tyler. “Unique Considerations for Performing Upper Extremity (UE) Isolated Limb Infusions (ILI).” In Annals of Surgical Oncology, 19:S125–S125. SPRINGER, 2012.
       Link to Item
    • Sharma, K., G. Beasley, R. Turley, and D. Tyler. “Patterns of Recurrence following Complete Response to Regional Chemotherapy for In-transit Melanoma.” In Annals of Surgical Oncology, 19:S23–S23. SPRINGER, 2012.
       Link to Item
    • Beasley, G. M., A. Selim, N. S. McMahon, A. Coleman, A. P. Abernethy, K. Nelson, S. K. Pruitt, et al. “Prospective Evaluation of PET/CT as a Surveillance Tool to Define Response to Therapy and Identify New Recurrent Disease in Patients with Locally Advanced Melanoma Undergoing Regional Chemotherapy Treatment with Melphalan.” In Annals of Surgical Oncology, 17:S115–S115. SPRINGER, 2010.
       Link to Item
    • Beasley, G. M., N. McMahon, G. Sanders, A. Coleman, J. Padussis, J. S. Zager, S. N. Hochwald, et al. “Final Results of a Prospective Multi-Center Phase II Trial of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients with Advanced Extremity Melanoma.” In Annals of Surgical Oncology, 17:S21–S21. SPRINGER, 2010.
       Link to Item
    • Turaga, K. K., G. M. Beasley, R. J. Gonzalez, K. A. Delman, G. D. Letson, D. Cheong, D. S. Tyler, and J. S. Zager. “Limb Preservation with Isolated Limb Infusion for Unresectable Non-melanoma Cutaneous and Soft Tissue Malignancies.” In Annals of Surgical Oncology, 17:S32–S32. SPRINGER, 2010.
       Link to Item
    • Beasley, G., G. Sanders, J. S. Zager, S. N. Hochwald, S. Grobmyer, R. H. Andtbacka, B. Peterson, W. P. Peters, M. I. Ross, and D. S. Tyler. “A prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion (M-ILI) in patients with advanced extremity melanoma.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
       Link to Item
    • McMahon, N., G. M. Beasley, G. Sanders, C. Augustine, J. Padussis, A. Coleman, M. A. Selim, B. Peterson, M. S. Brady, and D. S. Tyler. “A phase I study of systemic sorafenib in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” In Journal of Clinical Oncology, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
       Link to Item
    • McMahon, Nicole, Douglas Tyler, and Georgia Beasley. “Isolated limb infusion with melphalan for the treatment of advanced nonmelanoma cutaneous malignancies.” In Journal of the American Academy of Dermatology, 60:AB139–AB139. MOSBY-ELSEVIER, 2009.
       Link to Item
    • Beasley, G. M., N. McMahon, G. Sanders, C. K. Augustine, P. Zipfel, J. Padussis, M. A. Selim, et al. “Targeting N-cadherin to Enhance Cytotoxicity of Melphalan in Regional Chemotherapy: Final Results of a Phase I Study of Systemic ADH-1 in Combination with Melphalan via Isolated Limb Infusion (M-ILI) in Patients (pts) with Locally Advanced In-transit Malignant Melanoma.” In Annals of Surgical Oncology, 16:2–3. SPRINGER, 2009.
       Link to Item
    • Beasley, G., N. McMahon, G. Sanders, P. Zipfel, C. Augustine, W. Petros, J. Padussis, et al. “A phase I/II study of systemic ADH-1 in combination with isolated limb infusion with melphalan (ILI-M) in patients (pts) with locally advanced in-transit melanoma.” In Journal of Clinical Oncology, 26:9013–9013. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.9013.
       Full Text
    • Beasley, G., R. Petersen, J. Yoo, T. Aloia, W. Petros, G. Sanders, C. Tsung, S. Pruitt, H. Seigler, and D. Tyler. “Isolated limb infusion for in-transit malignant melanoma of the extremity: A well tolerated but less effective alternative to hyperthermic isolated limb perfusion.” In Annals of Surgical Oncology, 15:3–3. SPRINGER, 2008.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.